Peri-implant soft-tissue augmentation interventions are indicated prior to or after insertion of the final implant-supported prosthesis in sites presenting unfavorable structural features that are associated with or may predispose to the occurrence of inflammatory peri-implant pathosis, soft-tissue deformities, and/or suboptimal esthetics . Depending on their primary therapeutic goal, peri-implant soft-tissue augmentation interventions may be broadly classified into two categories: (1) Peri-implant soft-tissue phenotype modification and (2) Treatment of peri-implant marginal mucosa defects (PMMDs), also known as periimplant soft-tissue dehiscences.
发表评论